Metropolis Healthcare Limited (METROPOLIS.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+69.1%

₹959.28

vs ₹567.20 price

Levered DCF

₹1,011.58

After debt service

Piotroski score

4 / 9

Average

Altman Z-score

—

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	47.23×	54.18×	69.59×	44.89×	48.62×	62.31×	50.65×	39.89×
P/B	5.93×	5.9×	8.14×	6.49×	11.81×	16.23×	12.37×	11.47×
P/S	5.45×	5.9×	7.39×	5.58×	8.52×	11.49×	7.56×	6.31×
EV / EBITDA	21.92×	26.35×	31.28×	22.57×	31.25×	38.82×	27.57×	23.47×
Gross margin	47.8%	77.2%	77.7%	76.1%	75.8%	72.9%	74.6%	75.7%
Operating margin	16.2%	40.3%	42.1%	42.9%	45.3%	44.7%	43.7%	42.1%
Net margin	11.5%	10.9%	10.6%	12.4%	17.4%	18.3%	14.9%	15.8%
Current ratio	1.4×	1.18×	1.28×	1.14×	1.3×	2.98×	2.34×	2.45×
Debt / equity	0.15×	0.15×	0.18×	0.27×	0.43×	0.16×	0.13×	0.04×
Interest coverage	10.88×	22.45×	18.25×	15.51×	22.52×	40.25×	31.04×	86.29×
Dividend yield	0.2%	0.0%	0.2%	0.6%	0.4%	0.4%	0.7%	1.4%
Payout ratio	10.9%	0.0%	16.0%	28.7%	19.1%	22.3%	38.0%	55.4%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	12.6%	10.9%	11.7%	14.5%	24.2%	25.9%	24.3%	28.7%
Return on invested capital	10.4%	24.5%	27.2%	27.9%	29.8%	40.2%	46.9%	49.1%
Return on assets	8.9%	7.8%	8.2%	9.5%	14.0%	18.2%	16.9%	21.7%
Free cash flow yield	3.3%	2.8%	2.2%	3.0%	2.1%	1.9%	2.8%	1.4%
Earnings yield	2.1%	1.8%	1.4%	2.2%	2.0%	1.6%	2.0%	2.5%
Enterprise value	₹91.5B	₹80.2B	₹90.6B	₹66.1B	₹107.8B	₹111.9B	₹64.4B	₹47.7B
Net debt / EBITDA	0.42×	0.54×	0.46×	0.67×	0.91×	-0.95×	-0.17×	-0.17×
Cash conversion cycle (days)	2	-53	-44	-26	-5	-49	-46	37